My ePortfolio Register   

Bladder cancer's relationship with the urinary and gut microbiomes

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.09.17
Views: 1160

Dr Jeremy Burton - Lawson Health Research Institute, London, Canada

Dr Jeremy Burton talks to ecancer at the Microbiome in Cancer and Beyond 2017 meeting about his talk concerning the relationship between bladder cancer and the urinary and gut microbiomes. He discusses the risks that could arise during polymerase chain reaction (PCR) and sequencing due to a high potential for contamination and artefacts.

Dr Burton's research field is relatively understudied, and he believes there is still more to be found concerning this complex relationship. He also wants to delve further into the impact of certain cancer drugs on these microbiomes as they could have negative associations with other systems. Recent data surrounding the regulation of testosterone also goes some way to provide an explanation for the resistant characteristics of some drugs.

He ends by underlining the technical difficulty surrounding the future of his research, particularly without a large number of resources. The youth of this particular field also means there are many avenues that could be pursued. Without much further research prevention will be limited to relatively crude methods such as transplantation or probiotics.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence